Citadel-Advisors

Filing Details

13F-HR • 2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
8,968
Total Value
118920190514
Accession Number
0000950123-25-005687
Form Type
13F-HR
Manager Name
Citadel-Advisors
Data Enrichment
73% identified
6,557 identified2,411 unidentified

Holdings

8,968 positions • $118.9B total value
Manager:
Search and click to pin securities to the top
Page 320 of 321
70387R122
Shares:41.7K
Value:$234
% of Portfolio:0.0% ($234/$118.9B)
53620U110
Shares:35.0K
Value:$207
% of Portfolio:0.0% ($207/$118.9B)
83425V104
Shares:1.1K
Value:$192
% of Portfolio:0.0% ($192/$118.9B)
G4619M117
Shares:10.2K
Value:$183
% of Portfolio:0.0% ($183/$118.9B)
Entera Bio Ltd.
Shares:100
Value:$170
% of Portfolio:0.0% ($170/$118.9B)
NATIONAL FUEL GAS CO
Shares:2
Value:$158
% of Portfolio:0.0% ($158/$118.9B)
G72245114
Shares:12.8K
Value:$138
% of Portfolio:0.0% ($138/$118.9B)
19207A116
Shares:11.8K
Value:$130
% of Portfolio:0.0% ($130/$118.9B)
NANOVIRICIDES, INC.
Shares:100
Value:$117
% of Portfolio:0.0% ($117/$118.9B)
83542D110
Shares:13.3K
Value:$92
% of Portfolio:0.0% ($92/$118.9B)
FORWARD AIR CORP
Shares:4
Value:$80
% of Portfolio:0.0% ($80/$118.9B)
Safety Shot, Inc.
Shares:200
Value:$73
% of Portfolio:0.0% ($73/$118.9B)
PAVmed Inc.
Shares:100
Value:$72
% of Portfolio:0.0% ($72/$118.9B)
PEGASYSTEMS INC
Shares:1
Value:$70
% of Portfolio:0.0% ($70/$118.9B)
345523203
Shares:100
Value:$65
% of Portfolio:0.0% ($65/$118.9B)
CytomX Therapeutics, Inc.
Shares:100
Value:$64
% of Portfolio:0.0% ($64/$118.9B)
INCYTE CORP
Shares:1
Value:$61
% of Portfolio:0.0% ($61/$118.9B)
00444T209
Shares:100
Value:$50
% of Portfolio:0.0% ($50/$118.9B)
INTERPUBLIC GROUP OF COMPANIES, INC.
Shares:1
Value:$27
% of Portfolio:0.0% ($27/$118.9B)
PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Shares:22
Value:$26
% of Portfolio:0.0% ($26/$118.9B)